Lorus Therapeutics Inc
Lorus Therapeutics Inc. (TSX: LOR) (the “Company”), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer.
Transactions
This announcement as a matter of record only
PowerOne acted as Member of Selling Group in connection with this financing
This announcement as a matter of record only
PowerOne acted as Member of Selling Group in connection with this financing
News
TORONTO, ONTARIO--(Marketwired - Dec 10, 2013) - Lorus Therapeutics Inc (TSX:LOR) ("Lorus" or the "Company") has completed today its previously announced public offering of common shares of the...
Dr Aiping Young reports LORUS THERAPEUTICS CLOSES $66 MILLION PRIVATE PLACEMENT Lorus Therapeutics Inc has completed its previously announced private placement of 20,625,000 units at a subscription...
About
PowerOne is a long term investor focused on providing early stage capital and advisory services to emerging growth companies. Since inception in 2003, PowerOne has assisted private and public companies across an array of sectors globally.
PowerOne is an Exempt Market Dealer and is registered in Ontario, British Columbia, Alberta, Saskatchewan, Manitoba, Nova Scotia and Quebec.
